↓ Skip to main content

Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study

Overview of attention for article published in BMC Infectious Diseases, December 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study
Published in
BMC Infectious Diseases, December 2021
DOI 10.1186/s12879-021-06982-z
Pubmed ID
Authors

O. V. Stanevich, D. S. Fomina, I. G. Bakulin, S. I. Galeev, E. A. Bakin, V. A. Belash, A. N. Kulikov, A. A. Lebedeva, D. A. Lioznov, Yu. S. Polushin, I. V. Shlyk, E. A. Vorobyev, S. V. Vorobyeva, T. V. Surovceva, N. V. Bakulina, M. A. Lysenko, I. S. Moiseev

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 11%
Other 3 7%
Researcher 3 7%
Student > Bachelor 2 4%
Lecturer 2 4%
Other 7 15%
Unknown 24 52%
Readers by discipline Count As %
Medicine and Dentistry 8 17%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Environmental Science 2 4%
Biochemistry, Genetics and Molecular Biology 1 2%
Nursing and Health Professions 1 2%
Other 4 9%
Unknown 28 61%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2021.
All research outputs
#4,167,289
of 22,769,322 outputs
Outputs from BMC Infectious Diseases
#1,341
of 7,668 outputs
Outputs of similar age
#101,300
of 496,233 outputs
Outputs of similar age from BMC Infectious Diseases
#42
of 195 outputs
Altmetric has tracked 22,769,322 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,668 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 496,233 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 195 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.